Clinical trial · Observational
Pilot Study About Tamoxifen Therapy for Breast Cancer Patients
Pilot Study to Evaluate the Knowledge and Understanding on Tamoxifen Therapy for Breast Cancer Patients
NCT02094495CI-TRIAL-00014953unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study are to to evaluate the knowledge and understanding on tamoxifen theraphy for breast cancer patients and examine the decision conflict scale and satisfaction with decision scale while making decision to take tamoxifen.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- breast cancer group
- description
- Taking tamoxifen
Primary outcomes (1)
- measure
- The knowledge questionnaire about tamoxifen
- timeFrame
- The study outcome measure will be assessed by face-to-face, one time.
- description
- There are no more follow up except one time
Secondary outcomes (1)
- measure
- Decision Conflict Scale
- timeFrame
- The study outcome measure will be assessed by face-to-face , one time.
- description
- There are no more follow up except one time.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * The breast cancer patients who take tamoxifenExclusion Criteria: Exclusion criteria * The patients who do not agree to participate in this study * The paitents who have trouble with understanding and reading Korean.
References
Publications (0)
Data not yet available
No reference posted for this study.